Primary hypertension elastomer subcutaneous implant rod
An essential hypertension and flexible technology, applied in the direction of organic active ingredients, cardiovascular system diseases, medical preparations of non-active ingredients, etc., can solve the problems of human discomfort and poor effect, avoid allergens and reduce side effects , good biocompatibility effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
preparation example Construction
[0042] The present invention adopts the ternary copolymerization method to prepare the drug carrier for the implanted rod without adding other chemical catalyst substances, and avoids the problem of allergens caused by adding other catalyst substances in other preparation methods. A method for preparing a hypertensive elastomeric subcutaneous implant rod, comprising the following steps:
[0043] The first step, the preparation of modified polycaprolactone: first put the above-mentioned parts of polycaprolactone and polyethylene glycol into the reaction kettle, stir while heating, the heating temperature is 100~150°C, stir for 5h, When the raw materials in the reaction kettle are in a viscous state, add the above-mentioned parts of polyvinylpyrrolidone and fully stir and mix for 1 hour to obtain the modified polycaprolactone;
[0044] The second step, the preparation of the implant rod: add the above-mentioned parts of enalapril, lacidipine, and irbesartan to the modified polyc...
Embodiment 1
[0046] The formula of this embodiment can produce the diameter of implant rod is 3mm, and length is 50mm, and the weight of each implant rod is 0.4g, and each implant rod contains raw material medicine is 0.13g.
[0047] Specifically, an elastomeric subcutaneous implant rod for essential hypertension, the formula of which is: polycaprolactone 200g, 400 molecular weight polyethylene glycol 150g, polyvinylpyrrolidone 20g, enalapril 50g, Cidipine 50g, irbesartan 80g, total weight 550g, each 0.4g, about 1375 made.
[0048] The preparation process of the above-mentioned implanted rods is as follows: Weigh the raw materials and wait for use; first, put polycaprolactone and polyethylene glycol into the reaction kettle, stir at 140°C for 5 hours, and the raw materials in the reaction kettle will be in a viscous state. Add polyvinylpyrrolidone and continue stirring for 1 h to prepare modified polycaprolactone. When the modified polycaprolactone is cooled to 100°C, then add enalapril, ...
Embodiment 2
[0050] The formula of this embodiment can produce implanting rods with a diameter of 3mm and a length of 25mm, each implanting rod has a weight of 0.2g, and each implanting rod contains 0.074g of raw material medicine.
[0051] Wherein, the specific formula of this embodiment is: polycaprolactone 100g, polyethylene glycol 70g, polyvinylpyrrolidone 15g, enalapril 30g, lacidipine 30g, irbesartan 48g, total weight 293g, each 0.2g, made into about 1465 sticks.
[0052]The preparation method of this embodiment is the same as that of Example 1.
PUM
Property | Measurement | Unit |
---|---|---|
Diameter | aaaaa | aaaaa |
Length | aaaaa | aaaaa |
Diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com